Coronado Biosciences Inc (NASDAQ:CNDO) – Failure Of Study Makes Future Uncertain

Boston, MA 10/15/2013 (wallstreetpr) – Coronado Biosciences Inc (NASDAQ:CNDO)’s future seems to be uncertain as the Crohn’s disease trial was unsuccessful in meeting the aim of improving the patients’ response to the disease. The company, focused on the development of drugs for the treatment of cancer and autoimmune disease, stated that the trial did not meet […]